About Atrantil
Atrantil is a company based in Dallas (United States) founded in 2012. It operates as a Direct-to-Consumer (D2C), and Reseller / Distribution. Atrantil has raised $2.38 million across 1 funding round. Atrantil offers products and services including Atrantil. Atrantil operates in a competitive market with competitors including Sova Health, Infinant Health, rmdy, G-NiiB and Advanced Biotics, among others.
- Headquarter Dallas, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Kbs Research
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.38 M (USD)
in 1 rounds
-
Latest Funding Round
$2.38 M (USD), Seed
Dec 14, 2015
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Atrantil
Atrantil offers a comprehensive portfolio of products and services, including Atrantil. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Atrantil is formulated to relieve bloating and discomfort.
Funding Insights of Atrantil
Atrantil has successfully raised a total of $2.38M through 1 strategic funding round. The most recent funding activity was a Seed round of $2.38 million completed in December 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $2.4M
-
First Round
First Round
(14 Dec 2015)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2015 | Amount | Seed - Atrantil | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Atrantil
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Atrantil
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Atrantil Comparisons
Competitors of Atrantil
Atrantil operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sova Health, Infinant Health, rmdy, G-NiiB and Advanced Biotics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Microbiome testing, consultations, and gut health supplements are offered.
|
|
| domain | founded_year | HQ Location |
Microbiome-based products to improve infant immune system
|
|
| domain | founded_year | HQ Location |
Developer of chewable tablets for improving digestion
|
|
| domain | founded_year | HQ Location |
Develops innovative microbiome-based technologies for disease diagnostics and treatments.
|
|
| domain | founded_year | HQ Location |
Developer of probiotics for gut health
|
|
| domain | founded_year | HQ Location |
Food supplements for gut health are developed by Ateria Health.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Atrantil
Frequently Asked Questions about Atrantil
When was Atrantil founded?
Atrantil was founded in 2012 and raised its 1st funding round 3 years after it was founded.
Where is Atrantil located?
Atrantil is headquartered in Dallas, United States. It is registered at Dallas, Texas, United States.
Is Atrantil a funded company?
Atrantil is a funded company, having raised a total of $2.38M across 1 funding round to date. The company's 1st funding round was a Seed of $2.38M, raised on Dec 14, 2015.
What does Atrantil do?
Atrantil is created by a gastroenterologist to target bloating and abdominal discomfort originating in the small bowel. It is designed to eliminate gas-producing bacteria while acting as a prebiotic and postbiotic to support a healthier microbiome. The product is clinically tested with over 80 effectiveness in trials for digestive health issues. Solutions are provided for individuals experiencing diarrhea, constipation, or both, alongside general digestive health improvement. The company operates in the healthcare sector, focusing on dietary supplements for gut health.
Who are the top competitors of Atrantil?
Atrantil's top competitors include Sova Health, Infinant Health and rmdy.
What products or services does Atrantil offer?
Atrantil offers Atrantil.